Heart Rate Variability Wrist-Wearable Biomarkers Identify Adverse Posttraumatic Neuropsychiatric Sequelae after Traumatic Stress Exposure
Lauriane Guichard,Xinming An,Thomas C. Neylan,Gari D. Clifford,Qiao Li,Yinyao Ji,Lindsay Macchio,Justin Baker,Francesca L. Beaudoin,Tanja Jovanovic,Sarah D. Linnstaedt,Laura T. Germine,Kenneth A. Bollen,Scott L. Rauch,John P. Haran,Alan B. Storrow,Christopher Lewandowski,Paul I. Musey,Phyllis L. Hendry,Sophia Sheikh,Christopher W. Jones,Brittany E. Punches,Robert A. Swor,Nina T. Gentile,Jose L. Pascual,Mark J. Seamon,Elizabeth M. Datner,Claire Pearson,David A. Peak,Roland C. Merchant,Robert M. Domeier,Niels K. Rathlev,Brian J. O'Neil,Paulina Sergot,Leon D. Sanchez,Steven E. Bruce,John F. Sheridan,Steven E. Harte,Kerry J. Ressler,Karestan C. Koenen,Ronald C. Kessler,Samuel A. McLean
DOI: https://doi.org/10.1016/j.psychres.2024.116260
IF: 11.3
2024-11-11
Psychiatry Research
Abstract:Adverse posttraumatic neuropsychiatric sequelae (APNS) are common after traumatic events. We examined whether wrist-wearable devices could provide heart rate variability (HRV) biomarkers for recovery after traumatic stress exposure in a large socioeconomically disadvantaged cohort. Participants were enrolled in the emergency department within 72 hours after a traumatic event as part of the AURORA ( A dvancing U nderstanding of R ec O very afte R traum A ) multicenter prospective observational cohort study and followed over 6 months. HRV biomarkers were derived and validated for associations with specific APNS symptoms at a point in time and changes in symptom severity over time. Sixty-four HRV characteristics were derived and validated as cross-sectional biomarkers of APNS symptoms, including pain (26), re-experiencing (8), somatic (7), avoidance (7), concentration difficulty (6), hyperarousal (5), nightmares (1), anxiety (1), and sleep disturbance (3). Changes in 22 HRV characteristics were derived and validated as biomarkers identifying changes in APNS symptoms, including reexperiencing (11), somatic (3), avoidance (2), concentration difficulty (1), hyperarousal (1), and sleep disturbance (4). Changes in HRV variables over time predicted symptom improvement (PPV 0.68-0.87) and symptom worsening (NPV 0.71-0.90). HRV biomarkers collected from wrist-wearable devices may have utility as screening tools for APNS symptoms that occur after traumatic stress exposure in high-risk populations.
psychiatry